Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance (Q57694461)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Daniel Brewer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

S Jhavar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

J Bartlett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

G Kovacs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

C Corbishley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

D Dearnaley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

V Khoo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

R Huddart

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

A Horwich

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

A Thompson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

A Norman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

C S Cooper

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

C Parker

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

English

0 references

publication date

2 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

13 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

143-147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

Radical prostatectomy versus watchful waiting in early prostate cancer

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Continuing controversy over monitoring men with localized prostate cancer: a systematic review of programs in the prostate specific antigen era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Feasibility of constructing tissue microarrays from diagnostic prostate biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Construction of tissue microarrays from prostate needle biopsy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Tumor cell proliferation and survival in patients with prostate cancer followed expectantly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Proliferative index determination in prostatic carcinoma tissue: is there any additional prognostic value greater than that of Gleason score, ploidy and pathological stage?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Evaluation of Ki-67 monoclonal antibody as prognostic indicator for prostatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.47

31 March 2020

Identifiers

DOI

10.1038/PCAN.2008.47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18762814%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference